Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Cornelissen

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Journal of Labelled Compounds & Radiopharmaceuticals|January 8, 2014
Imaging the inside of a tumour: a review of radionuclide imaging and theranostics targeting intracellular epitopesBart Cornelissen
Cancer Biology & Therapy|February 27, 2009
Combination of EGFR signalling pathway inhibitors and prevention of resistanceBart Cornelissen
Current Opinion in Chemical Biology|May 29, 2021
Emerging chelators for nuclear imagingDeborah Sneddon, Bart Cornelissen
Journal of Labelled Compounds & Radiopharmaceuticals|August 30, 2021
Meet our advisors: Bart CornelissenBart Cornelissen, Paul Trevorrow
Nuclear Medicine and Biology|March 11, 2022
Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapyEdward O'Neill, Bart Cornelissen
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and RadiotherapyVeerle Kersemans, Bart Cornelissen
Current Drug Discovery Technologies|November 2, 2010
Targeting the nucleus: an overview of Auger-electron radionuclide therapyBart Cornelissen, Katherine A Vallis
American Journal of Nuclear Medicine and Molecular Imaging|April 23, 2014
Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapyJames C Knight, Bart Cornelissen
Theranostics|March 16, 2023
Imaging DNA damage response by γH2AX <i>in vivo</i> predicts treatment response to Lutetium-177 radioligand therapy and suggests senescence as a therapeutically desirable outcomeEdward O'Neill, Michael Mosley, Bart Cornelissen
Current Pharmaceutical Design|September 11, 2008
Cell penetrating peptides for in vivo molecular imaging applicationsVeerle Kersemans, Ken Kersemans, Bart Cornelissen
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Journal of Labelled Compounds & Radiopharmaceuticals|January 8, 2014
Imaging the inside of a tumour: a review of radionuclide imaging and theranostics targeting intracellular epitopesBart Cornelissen
Cancer Biology & Therapy|February 27, 2009
Combination of EGFR signalling pathway inhibitors and prevention of resistanceBart Cornelissen
Current Opinion in Chemical Biology|May 29, 2021
Emerging chelators for nuclear imagingDeborah Sneddon, Bart Cornelissen
Journal of Labelled Compounds & Radiopharmaceuticals|August 30, 2021
Meet our advisors: Bart CornelissenBart Cornelissen, Paul Trevorrow
Nuclear Medicine and Biology|March 11, 2022
Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapyEdward O'Neill, Bart Cornelissen
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and RadiotherapyVeerle Kersemans, Bart Cornelissen
Current Drug Discovery Technologies|November 2, 2010
Targeting the nucleus: an overview of Auger-electron radionuclide therapyBart Cornelissen, Katherine A Vallis
American Journal of Nuclear Medicine and Molecular Imaging|April 23, 2014
Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapyJames C Knight, Bart Cornelissen
Theranostics|March 16, 2023
Imaging DNA damage response by γH2AX <i>in vivo</i> predicts treatment response to Lutetium-177 radioligand therapy and suggests senescence as a therapeutically desirable outcomeEdward O'Neill, Michael Mosley, Bart Cornelissen
Current Pharmaceutical Design|September 11, 2008
Cell penetrating peptides for in vivo molecular imaging applicationsVeerle Kersemans, Ken Kersemans, Bart Cornelissen
Pageof 11